Latest Regulatory Filings News

Titanium Sands Limited has lodged an Industrial Mining License application for its Mannar Heavy Minerals Project in Sri Lanka, marking a pivotal step towards production. The project boasts a substantial mineral resource and is progressing through environmental and feasibility milestones despite recent cyclone delays.

Orthocell has reported a record $3.2 million in quarterly revenue, marking its seventh consecutive quarter of growth, driven by strong sales of its Remplir™ nerve repair product in Australia and early traction in the US market.

Nexsen Limited has initiated FDA engagement for its rapid Group B Streptococcus diagnostic sensor, aiming for expedited US market entry, while bolstering its leadership team and scientific credentials.

Arovella Therapeutics has taken a significant step forward by submitting an IND application to the U.S. FDA for its lead CAR-iNKT cell therapy, ALA-101, targeting blood cancers. This milestone paves the way for a first-in-human Phase 1 trial in both Australia and the U.S.

Memphasys Limited has completed a $579K shortfall placement, boosting total funds raised to over $1.12 million to support the commercial rollout of its Felix™ System following recent regulatory approvals.

JAYRIDE Group has amended its quarterly cash flow report to correct classification errors, while outlining plans for a new SaaS platform rollout and potential capital raising to support operations.

Kingsgate Consolidated has secured a US$25 million standby loan facility with Nebari, significantly reducing its debt and improving financing terms. This move marks a major step in the company’s de-gearing strategy while maintaining funding flexibility.

Atlantic Lithium has submitted a revised Mining Lease for its Ewoyaa Lithium Project to Ghana's Parliament, incorporating updated royalty rates aligned with new legislation. The lease awaits parliamentary ratification amid evolving fiscal terms.

Aurizon has lodged a proposed ten-year Network Access Undertaking with the Queensland Competition Authority, aiming to secure long-term certainty and enhanced operational incentives for the Central Queensland Coal Network.

Telix Pharmaceuticals reports positive Phase 3 results for its prostate cancer imaging agent Illuccix in China, paving the way for a near-term regulatory submission. Meanwhile, the company advances FDA resubmissions for its glioma and kidney cancer imaging candidates.

African Gold secures ASX waiver allowing cancellation of options without shareholder approval as part of Montage Gold acquisition scheme. This regulatory step smooths the path for the proposed takeover and option restructuring.

Dubber Corporation has secured a significant five-year contract with a leading North American telecommunications provider to deliver Mobile Voice Recording and AI-driven conversation analytics, marking a pivotal expansion in its global footprint.